Ad is loading...
LIANY
Price
$0.30
Change
-$0.00 (-0.00%)
Updated
Nov 15 closing price
18 days until earnings call
MTNB
Price
$0.62
Change
-$0.01 (-1.59%)
Updated
Nov 15 closing price
Ad is loading...

LIANY vs MTNB

Header iconLIANY vs MTNB Comparison
Open Charts LIANY vs MTNBBanner chart's image
LianBio
Price$0.30
Change-$0.00 (-0.00%)
Volume$121.76K
CapitalizationN/A
Matinas Biopharma Holdings
Price$0.62
Change-$0.01 (-1.59%)
Volume$45.11K
CapitalizationN/A
LIANY vs MTNB Comparison Chart
Loading...
View a ticker or compare two or three
VS
LIANY vs. MTNB commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LIANY is a Buy and MTNB is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (LIANY: $0.30 vs. MTNB: $0.62)
Brand notoriety: LIANY and MTNB are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: LIANY: 247% vs. MTNB: 18%
Market capitalization -- LIANY: $32.41M vs. MTNB: $3.11M
LIANY [@Biotechnology] is valued at $32.41M. MTNB’s [@Biotechnology] market capitalization is $3.11M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

LIANY’s FA Score shows that 1 FA rating(s) are green whileMTNB’s FA Score has 1 green FA rating(s).

  • LIANY’s FA Score: 1 green, 4 red.
  • MTNB’s FA Score: 1 green, 4 red.
According to our system of comparison, LIANY is a better buy in the long-term than MTNB.

Price Growth

LIANY (@Biotechnology) experienced а -0.03% price change this week, while MTNB (@Biotechnology) price change was -10.88% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

LIANY is expected to report earnings on Mar 24, 2025.

MTNB is expected to report earnings on Nov 06, 2024.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

FUNDAMENTALS
Fundamentals
LIANY($32.4M) has a higher market cap than MTNB($3.11M). LIANY YTD gains are higher at: 76.205 vs. MTNB (-94.265).
LIANYMTNBLIANY / MTNB
Capitalization32.4M3.11M1,042%
EBITDAN/A-22.8M-
Gain YTD76.205-94.265-81%
P/E RatioN/AN/A-
RevenueN/A0-
Total CashN/A6.22M-
Total DebtN/A3.24M-
FUNDAMENTALS RATINGS
MTNB: Fundamental Ratings
MTNB
OUTLOOK RATING
1..100
75
VALUATION
overvalued / fair valued / undervalued
1..100
19
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
99
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
26

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RSI
ODDS (%)
Stochastic
ODDS (%)
Momentum
ODDS (%)
MACD
ODDS (%)
TrendWeek
ODDS (%)
TrendMonth
ODDS (%)
Advances
ODDS (%)
Declines
ODDS (%)
BollingerBands
ODDS (%)
Aroon
ODDS (%)
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
VTC76.540.08
+0.10%
Vanguard Total Corporate Bond ETF
IEF93.320.04
+0.04%
iShares 7-10 Year Treasury Bond ETF
HSRT39.100.01
+0.03%
Hartford AAA CLO ETF
TEQI42.47N/A
N/A
T. Rowe Price Equity Income ETF
MMSC21.21-0.44
-2.03%
First Trust Multi-Manager Sm Cp Opps ETF

LIANY and

Correlation & Price change

A.I.dvisor indicates that over the last year, LIANY has been closely correlated with SER. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if LIANY jumps, then SER could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LIANY
1D Price
Change %
LIANY100%
N/A
SER - LIANY
69%
Closely correlated
-3.40%
GERN - LIANY
53%
Loosely correlated
-1.35%
TRML - LIANY
28%
Poorly correlated
-5.65%
OTLK - LIANY
23%
Poorly correlated
-1.81%
MTNB - LIANY
21%
Poorly correlated
-2.27%
More

MTNB and

Correlation & Price change

A.I.dvisor indicates that over the last year, MTNB has been loosely correlated with REGN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if MTNB jumps, then REGN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MTNB
1D Price
Change %
MTNB100%
-2.27%
REGN - MTNB
43%
Loosely correlated
-3.28%
ABCZF - MTNB
37%
Loosely correlated
N/A
SPRC - MTNB
35%
Loosely correlated
-1.82%
AXON - MTNB
34%
Loosely correlated
-0.86%
EQ - MTNB
34%
Loosely correlated
+3.71%
More